Livia

Livia sells a single, FDA-cleared wearable device designed to relieve menstrual cramps through pulsed electrical stimulation. Priced at USD 149–199 for starter bundles and up to USD 249 for expanded kits with extra gel pads and chargers, the brand sits in the mid-range wellness tech tier. Sales are handled exclusively through the company’s own site, mylivia.com, with global shipping from distribution centers in the U.S. and Europe. The product’s core claim is that it blocks pain “within 30 seconds” without drugs; clinical data cited on the site reports 80 % of users reducing or eliminating pain-medication use. Its compact, pastel-colored clip-on unit is paired with flower-shaped reusable electrodes, positioning the device as discreet, fashion-friendly tech rather than a medical appliance. Livia gained early visibility through a 2017 Indiegogo campaign that raised USD 1.7 million and continues to leverage user-generated before-and-after content for credibility. Primary buyers are women aged 18–35 who experience moderate-to-severe dysmenorrhea and prefer drug-free, on-the-go solutions compatible with school or office attire. The brand messaging emphasizes autonomy—“take back your day from period pain”—and aligns with values of body positivity, sustainability (reusable pads), and open discussion of menstrual health. Livia competes against both over-the-counter painkillers and a growing field of TENS-style period patches and app-connected cramp wearables. It differentiates by securing medical-device clearance, offering a lifetime warranty, and packaging the technology in a playful, lifestyle-oriented design that can be clipped to jeans like an MP3 player, distancing itself from clinical-looking alternatives.